Are GLP1s making us all weak?

About this video

In a reaction video, Gillett and his co-host dissect competing claims about GLP-1 medicines and muscle loss, responding to both a warning that users who do not train will age dramatically faster and a counter-claim that the drugs are beneficial no matter what. Gillett argues both extremes ignore who is being treated: he says trial populations are usually people with obesity or diabetes, not lean biohackers seeking cosmetic leanness. He contends lean-mass loss largely tracks calorie restriction and inactivity, while still warning that appetite oversuppression, sarcopenia, and serious adverse events are real concerns in the wrong patient.

Key takeaways

• Ask which population a GLP-1 claim comes from before applying it to yourself
• Protect muscle during weight loss with resistance training and adequate protein, as all sides in the debate advise
• Distinguish lean-mass loss expected from calorie restriction from loss caused by a drug itself
• Reject both ‘always harmful’ and ‘good no matter what’ framing of any intervention
• Consider baseline frailty and bone health before pursuing aggressive appetite suppression

Episode details: published November 14, 2025 · 364 views · 14:47 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: Gary Brecka back up your claims · Next: New Hair Loss Medication →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)